| Product Code: ETC13134650 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Precision Oncology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Precision Oncology Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 North America Precision Oncology Market - Industry Life Cycle |
3.4 North America Precision Oncology Market - Porter's Five Forces |
3.5 North America Precision Oncology Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 North America Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 North America Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Precision Oncology Market Trends |
6 North America Precision Oncology Market, 2021 - 2031 |
6.1 North America Precision Oncology Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Precision Oncology Market, Revenues & Volume, By Diagnostics, 2021 - 2031 |
6.1.3 North America Precision Oncology Market, Revenues & Volume, By Therapeutics, 2021 - 2031 |
6.2 North America Precision Oncology Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Precision Oncology Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.3 North America Precision Oncology Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.2.4 North America Precision Oncology Market, Revenues & Volume, By Cervical Cancer, 2021 - 2031 |
6.2.5 North America Precision Oncology Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.2.6 North America Precision Oncology Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.2.7 North America Precision Oncology Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Precision Oncology Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Precision Oncology Market, Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021 - 2031 |
6.3.3 North America Precision Oncology Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.3.4 North America Precision Oncology Market, Revenues & Volume, By Healthcare Data Companies, 2021 - 2031 |
7 North America Precision Oncology Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Precision Oncology Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Precision Oncology Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Precision Oncology Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Precision Oncology Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 United States (US) Precision Oncology Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Canada Precision Oncology Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 Rest of North America Precision Oncology Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.4 North America Precision Oncology Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.4.1 United States (US) Precision Oncology Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.4.2 Canada Precision Oncology Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.4.3 Rest of North America Precision Oncology Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 North America Precision Oncology Market Key Performance Indicators |
9 North America Precision Oncology Market - Export/Import By Countries Assessment |
10 North America Precision Oncology Market - Opportunity Assessment |
10.1 North America Precision Oncology Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.4 North America Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
11 North America Precision Oncology Market - Competitive Landscape |
11.1 North America Precision Oncology Market Revenue Share, By Companies, 2022 |
11.2 North America Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here